Literature DB >> 8035935

A clinical and pathologic study of a large Japanese family with Machado-Joseph disease tightly linked to the DNA markers on chromosome 14q.

Y Takiyama1, S Oyanagi, S Kawashima, H Sakamoto, K Saito, M Yoshida, S Tsuji, Y Mizuno, M Nishizawa.   

Abstract

The gene locus for Machado-Joseph disease (MJD) has been mapped to chromosome 14q by linkage analysis, mainly using a single large Japanese family. We studied the clinical and neuropathologic findings of this family with MJD, comparing them with those of spinocerebellar ataxia 1 (SCA1) and spinocerebellar ataxia 2 (SCA2) families. The pedigree included 30 affected persons in 125 members of five generations. Neurologic examination of 21 patients revealed that dystonia, difficulty in eyelid opening, slowness of movements, bulging eyes, and facial-lingual fasciculation-like movements or myokymia are characteristic of this MJD family, although these three autosomal dominant spinocerebellar degenerations have several neurologic signs and symptoms in common. In contrast with SCA1 and SCA2, degeneration of the subthalamopallidal system and relative sparing of the olivocerebellar system were the main neuropathologic features of MJD.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8035935     DOI: 10.1212/wnl.44.7.1302

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  34 in total

Review 1.  Metabolic profiles to define the genome: can we hear the phenotypes?

Authors:  Julian L Griffin
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2004-06-29       Impact factor: 6.237

Review 2.  Using the shared genetics of dystonia and ataxia to unravel their pathogenesis.

Authors:  Esther A R Nibbeling; Cathérine C S Delnooz; Tom J de Koning; Richard J Sinke; Hyder A Jinnah; Marina A J Tijssen; Dineke S Verbeek
Journal:  Neurosci Biobehav Rev       Date:  2017-01-28       Impact factor: 8.989

Review 3.  Machado-Joseph disease/spinocerebellar ataxia type 3.

Authors:  Henry Paulson
Journal:  Handb Clin Neurol       Date:  2012

4.  Genotyping and prenatal diagnosis of a large spinocerebellar ataxia pedigree in northeastern China.

Authors:  Dong-Hua Cao; Xiao-Li Liu; Guang-Bin Qiu
Journal:  J Genet       Date:  2011-08       Impact factor: 1.166

5.  Inflammatory genes are upregulated in expanded ataxin-3-expressing cell lines and spinocerebellar ataxia type 3 brains.

Authors:  B O Evert; I R Vogt; C Kindermann; L Ozimek; R A de Vos; E R Brunt; I Schmitt; T Klockgether; U Wüllner
Journal:  J Neurosci       Date:  2001-08-01       Impact factor: 6.167

6.  Machado-Joseph disease mutations as the genetic basis of most spinocerebellar ataxias in Germany.

Authors:  L Schöls; G Amoiridis; M Langkafel; T Büttner; H Przuntek; O Riess; A M Vieira-Saecker; J T Epplen
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-10       Impact factor: 10.154

7.  Oculographic findings in traumatic unconsciousness: prognostic implications.

Authors:  N M Kane; K Rowlands; R J Nelson; T Moss
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-10       Impact factor: 10.154

8.  Prenatal diagnosis of Machado-Joseph disease/Spinocerebellar Ataxia Type 3 in Taiwan: early detection of expanded ataxin-3.

Authors:  Hui-Fang Tsai; Chin-San Liu; Gin-Den Chen; Mei-Ling Lin; Chuan Li; Yi-Yun Chen; Bao-Tyan Wang; Mingli Hsieh
Journal:  J Clin Lab Anal       Date:  2003       Impact factor: 2.352

9.  High frequency of Machado-Joseph disease identified in southeastern Chinese kindreds with spinocerebellar ataxia.

Authors:  Shi-Rui Gan; Sheng-Sheng Shi; Jian-Jun Wu; Ning Wang; Gui-Xian Zhao; Sheng-Tong Weng; Shen-Xing Murong; Chuan-Zhen Lu; Zhi-Ying Wu
Journal:  BMC Med Genet       Date:  2010-03-25       Impact factor: 2.103

10.  Linear T2 hyperintensity along the medial margin of the globus pallidus in patients with Machado-Joseph disease and Parkinson disease, and in healthy subjects.

Authors:  W Shirai; S Ito; T Hattori
Journal:  AJNR Am J Neuroradiol       Date:  2007-09-26       Impact factor: 3.825

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.